Charles Schwab’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-29,898
Closed -$295K 3614
2023
Q1
$295K Buy
29,898
+5,000
+20% +$49.4K ﹤0.01% 3093
2022
Q4
$237K Buy
24,898
+14,709
+144% +$140K ﹤0.01% 3153
2022
Q3
$178K Hold
10,189
﹤0.01% 3176
2022
Q2
$79K Buy
+10,189
New +$79K ﹤0.01% 3307